Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

Abstract Background The ability of 18F-PI-2620 PET to measure the spatial distribution of tau pathology in Alzheimer’s disease (AD) has been demonstrated in previous studies. The objective of this work was to evaluate tau deposition using 18F-PI-2620 PET in beta-amyloid positive subjects with a diag...

Full description

Bibliographic Details
Main Authors: Santiago Bullich, Andre Mueller, Susan De Santi, Norman Koglin, Stephen Krause, June Kaplow, Michio Kanekiyo, Núria Roé-Vellvé, Audrey Perrotin, Aleksandar Jovalekic, David Scott, Michelle Gee, Andrew Stephens, Michael Irizarry
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Alzheimer’s Research & Therapy
Subjects:
PI-2620
Florbetaben
Tau
Amyloid-beta
Mild cognitive impairment
Alzheimer’s disease
Online Access:https://doi.org/10.1186/s13195-022-01048-x

Internet

https://doi.org/10.1186/s13195-022-01048-x

Similar Items